Social Media Influencers Driving Parallel Trade for Unlicensed Slimming Drug
A shadow market for unlicensed slimming medications is propelled by social media fitness personalities and sellers on messaging platforms, according to recent findings.
Investigational Drug Gaining Popularity Via Social Media
Retatrutide, which is still in research studies, is being advertised by social media influencers for its supposed weight-reducing properties. Followers are urged to message these accounts privately for source information, while also obtaining promotional offers.
Active Trade on Messaging Platforms
Additionally, a robust market exists on Telegram, where groups with numerous of participants share comparison images, injection guides and claims of rapid UK delivery. Vendors promote the drug there before directing customers to WhatsApp for purchases.
Understanding The Experimental Drug
Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials suggest it could help patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the substance is being promoted digitally as the next Ozempic.
Healthcare Experts Express Concerns
However, doctors and chemists have warned that the distribution of what remains an unapproved medication in the UK is worrisome and could lead to users administering products of unknown origin.
Several experts stated the demand for the experimental drug could be connected to the increasing cost of licensed weight loss products such as Mounjaro.
Legal Status and Implementation
Selling the unapproved drug on social media or messaging apps is prohibited in the UK, as it is an unapproved drug that must not be marketed or distributed for personal consumption under the British medical regulations.
Several influencers try to circumvent the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and distribution can still breach medicines, advertising, and consumer laws, potentially leading to penalties, legal action or prison.
Platform Reaction and Content Removal
According to the social media company, the platform has removed problematic material and banned related keywords and search suggestions. The company said it was dedicated to maintaining the platform safe and investing in enhancing compliance measures.
Digital Marketplace Activities
Research also found communities with up to 9,000 members marketing retatrutide using the platform's integrated discovery tool, which operates like a public directory. Typing “retatrutide” instantly brings up groups with numerous of members, populated with images of weight loss, positive reviews and step-by-step guides for mixing or injecting at home.
After minutes of joining one community, a seller shared WhatsApp details, where most transactions take place. The seller sent an instruction manual and promised delivery within 48 hours. When asked whether the substance was authentic, one vendor said: “You can’t be sure.” Another shared a photo of a supposed testing documentation. Not one inquired about weight, medical conditions or past usage.
Product Information and Costs
Within these communities, messages display black plastic packages with postal service stickers, stating to contain new batches. One communication stated: “It took eight of us to load them this morning.”
Buyers can select between powder vials, mixed at home with sterile water, or pre-filled pens typically priced at 160 pounds for 20mg. When asked how much time a injector should last, vendors give contradictory answers ranging from a few weeks to “depends on your body”.
Service Oversight and Safety Actions
A spokesperson for the messaging service said it actively monitored dangerous material on its platform including content that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Medical Expert Cautions
“Individuals are administering materials they cannot confirm. Although the research behind retatrutide is sound, these online versions may not include what they claim,” stated a pharmacy expert, the head of pharmacy at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor linked the increase in interest to current price rises for approved slimming drugs such as Mounjaro. “With prices increasing, individuals are turning to social media. But counterfeit injections are highly dangerous. You cannot know what’s inside or whether the conditions they were produced in was sterile,” she explained.
Her staff has already encountered patients harmed by self-injection from unverified sources. “We understand the disappointment, but buying from messaging apps or communication platforms is taking chances with your well-being,” said Wyllie. “These materials could be contaminated or improperly measured.”
Producer Position
A spokesperson from the pharmaceutical company said the substance was in phase 3 research studies and had not been reviewed or approved by any regulatory agency anywhere in the world. “Consequently at this time no one can sell [it] for personal consumption,” they said, noting that any item “falsely representing itself as a company investigational product not yet authorized … may expose users to possibly serious medical dangers”.